Amyloid Imaging in Atypical Presentations of Alzheimer's Disease

被引:24
|
作者
Wolk, David A. [1 ,2 ]
机构
[1] Univ Penn, Dept Neurol, Philadelphia, PA 19104 USA
[2] Univ Penn, Penn Memory Ctr, Philadelphia, PA 19104 USA
关键词
Atypical dementia; Logopenic progressive aphasia; Posterior cortical atrophy; Frontal variant of Alzheimer's disease; Amyloid imaging; POSTERIOR CORTICAL ATROPHY; PRIMARY-PROGRESSIVE-APHASIA; FRONTOTEMPORAL LOBAR DEGENERATION; POSITRON-EMISSION-TOMOGRAPHY; MILD COGNITIVE IMPAIRMENT; PITTSBURGH COMPOUND-B; CLINICOPATHOLOGICAL CORRELATIONS; CLINICAL CHARACTERISTICS; METABOLIC DEFICITS; NATIONAL INSTITUTE;
D O I
10.1007/s11910-013-0412-x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Alzheimer's disease (AD) is thought to progress in a fairly stereotyped manner, with episodic memory loss being the first and most salient domain of impairment, reflecting the early disease in structures supporting this function. However, there is considerable heterogeneity in the relative involvement of different cognitive domains, and at the extreme are three syndromes associated with AD: (1) logopenic progressive aphasia, (2) posterior cortical atrophy, and (3) frontal variant of AD. As each of these syndromes is variably associated with non-AD dementia and clinically overlaps with other presentations more commonly associated with different causes of neurodegeneration (e. g., progressive nonfluent aphasia), the use of amyloid imaging for detection of the molecular pathologic features of AD is of significant clinical value. This article reviews several amyloid imaging studies of these populations which support autopsy case series and reveal a dissociation between the spatial distribution of amyloid plaques and clinical phenotype.
引用
收藏
页数:7
相关论文
共 50 条
  • [41] Prospects for noninvasive imaging of drain amyloid β in Alzheimer's disease
    Friedland, RP
    Shi, J
    Lamanna, JC
    Smith, MA
    Perry, G
    VASCULAR FACTORS IN ALZHEIMER'S DISEASE, 2000, 903 : 123 - 128
  • [42] Atypical presentations of primary amyloid neuropathy
    Vucic, S
    Chong, PST
    Cros, D
    MUSCLE & NERVE, 2003, 28 (06) : 696 - 702
  • [43] Amyloid and Alzheimer's disease
    Lei, Hongxing
    PROTEIN & CELL, 2010, 1 (04) : 312 - 314
  • [44] Multiphoton in vivo imaging of amyloid in animal models of Alzheimer's disease
    Dong, Jinghui
    Revilla-Sanchez, Raquel
    Moss, Stephen
    Haydon, Philip G.
    NEUROPHARMACOLOGY, 2010, 59 (4-5) : 268 - 275
  • [45] Radiolabeled bioactive benzoheterocycles for imaging β-amyloid plaques in Alzheimer's disease
    Yang, Yanping
    Cui, Mengchao
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2014, 87 : 703 - 721
  • [46] Amyloid imaging of Alzheimer's disease using Pittsburgh Compound B
    Johnson, Keith A.
    CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2006, 6 (06) : 496 - 503
  • [47] Optical Imaging of Beta-Amyloid Plaques in Alzheimer's Disease
    Luo, Ziyi
    Xu, Hao
    Liu, Liwei
    Ohulchanskyy, Tymish Y.
    Qu, Junle
    BIOSENSORS-BASEL, 2021, 11 (08):
  • [48] Development of a PET/SPECT agent for amyloid imaging in Alzheimer’s disease
    Yanming Wang
    William E. Klunk
    Manik L. Debnath
    Guo-Feng Huang
    Daniel P. Holt
    Li Shao
    Chester A. Mathis
    Journal of Molecular Neuroscience, 2004, 24 : 55 - 62
  • [49] Amyloid PET imaging in Alzheimer's disease: a comparison of three radiotracers
    Landau, S. M.
    Thomas, B. A.
    Thurfjell, L.
    Schmidt, M.
    Margolin, R.
    Mintun, M.
    Pontecorvo, M.
    Baker, S. L.
    Jagust, W. J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 (07) : 1398 - 1407
  • [50] Views and Perceptions of Amyloid Imaging in a Preclinical Alzheimer's Disease Trial
    Ritchie, M.
    Raman, R.
    Ernstrom, K.
    Wang, S.
    Donohue, M. C.
    Aisen, P.
    Henley, D.
    Romano, G.
    Novak, G. P.
    Brashear, H. R.
    Sperling, R. A.
    Grill, J. D.
    JPAD-JOURNAL OF PREVENTION OF ALZHEIMERS DISEASE, 2024, 11 (06): : 1563 - 1571